Treating children with tuberculosis-Using pharmacometrics to do better

Br J Clin Pharmacol. 2022 Mar;88(3):894-896. doi: 10.1111/bcp.15220. Epub 2022 Jan 18.

Author

Helen McIlleron^{1

2}

Affiliations

¹ Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
² Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

PMID: 35043431
DOI: 10.1111/bcp.15220

No abstract available

Keywords: dose; paediatric; pharmacokinetics; tuberculosis treatment.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antitubercular Agents / adverse effects
Child
Humans
Tuberculosis* / drug therapy

Substances

Antitubercular Agents

Grants and funding

206379/Z/17/Z/WT_/Wellcome Trust/United Kingdom